List view / Grid view
Medical screening is a strategy used to identify the possible presence of an as-yet-undiagnosed disease in individuals without signs or symptoms.
15 June 2016 | By Merck KGaA
We offer an extensive, focused portfolio of antibodies and immunoassays, including validated antibodies for effective immunoprecipitation of chromatin, RNA-binding proteins, modified histones, and transcriptional proteins...
14 June 2016 | By Charles River
This webinar reviews successful high throughput screening programs to provide an overview of the process from assay development to final data package...
Cancer cells exhibit huge phenotypic diversity, with many well-defined phenotypes, such as invasion, deregulated proliferation and immune evasion, contributing to disease outcomes, making them uniquely amenable to phenotypic screening1...
2 June 2016 | By Merck KGaA
EMD Millipore’s extensive portfolio of validated antibodies help unravel the complexities of stem cell research...
10 May 2016 | By Merck KGaA
Complete product portfolio for the study of cell structure, intracellular signaling, extracellular environment, and cellular migration and invasion...
28 April 2016 | By Merck KGaA
Each of EMD Millipore’s ChIPAb+™ and RIPAb+™ antibodies are validated and tested for ChIP and RNA immunoprecipitation (RIP)...
12 April 2016 | By Merck KGaA
As a leading provider of antibodies for cell signaling research, EMD Millipore is advancing life science research and therapeutic development...
11 April 2016 | By Victoria White, Digital Content Producer
New research could pave the way for a new generation of anti-diabetic drugs that are activated by the presence of either blue or ultra-violet light...
17 March 2016 | By Merck KGaA
EMD Millipore offers an extensive, focused portfolio of immunoassays and validated antibodies for effective immunoprecipitation of chromatin, RNA-binding proteins, modified histones, and transcriptional proteins...
17 March 2016 | By BMG Labtech
BMG LABTECH has developed the new reference multi-mode microplate PHERAstar® FSX reader for HTS applications. This reader was specifically conceived for the fastest read times, the best sensitivity and unmatched flexibility in all plate formats up to 3456 wells...
16 March 2016 | By Victoria White
Researchers from NIST have shown that high-throughput screening can dramatically speed up the challenging task of antimicrobial discovery...
1 March 2016 | By Merck KGaA
With EMD Millipore’s comprehensive portfolio of reagents and antibodies, researchers can count on dependable, high-quality solutions for analysing all the hallmarks of cancer...
23 February 2016 | By DiscoverX Corporation
PathHunter cell-based pharmacotrafficking assays provide a simple and quantitative tool for broad pharmacological characterisation and interrogation of compound function in disease processes associated with protein trafficking and internalization due to protein misfolding...
23 February 2016 | By DiscoverX Corporation
The most comprehensive kinase inhibitor screening panel with over 480 kinase assays to screen against on a single technology platform...
22 February 2016 | By DiscoverX Corporation
The KILR Cytotoxicity Assay is a simple, non-radioactive and dye-free method to specifically measure target cancer cell cytotoxicity...
